Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records

Pilot program combines clinician-guided phenotypes with IMO Health’s terminology identifiers to help clinicians identify patients most likely to benefit from Pivot insulin pump therapy. The initiative is advancing toward a fourth-quarter commercial launch of the Pivot pump, with no specific clinical or financial metrics disclosed in the provided text.

Analysis

Pilot program combines clinician-guided phenotypes with IMO Health’s terminology identifiers to help clinicians identify patients most likely to benefit from Pivot insulin pump therapy. The initiative is advancing toward a fourth-quarter commercial launch of the Pivot pump, with no specific clinical or financial metrics disclosed in the provided text.